- Home
- AXTA vs ARWR Comparison
AXTA vs ARWR Comparison
Compare AXTA & ARWR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXTA
- ARWR
- Stock Information
- Founded
- AXTA 1910
- ARWR 2003
- Country
- AXTA United States
- ARWR United States
- Employees
- AXTA N/A
- ARWR N/A
- Industry
- AXTA Paints/Coatings
- ARWR Biotechnology: Pharmaceutical Preparations
- Sector
- AXTA Consumer Discretionary
- ARWR Health Care
- Exchange
- AXTA Nasdaq
- ARWR Nasdaq
- Market Cap
- AXTA 6.2B
- ARWR 5.9B
- IPO Year
- AXTA 2014
- ARWR 1993
- Fundamental
- Price
- AXTA $28.97
- ARWR $39.23
- Analyst Decision
- AXTA Buy
- ARWR Strong Buy
- Analyst Count
- AXTA 14
- ARWR 8
- Target Price
- AXTA $37.36
- ARWR $47.75
- AVG Volume (30 Days)
- AXTA 4.5M
- ARWR 1.7M
- Earning Date
- AXTA 10-28-2025
- ARWR 11-25-2025
- Dividend Yield
- AXTA N/A
- ARWR N/A
- EPS Growth
- AXTA 40.67
- ARWR N/A
- EPS
- AXTA 2.09
- ARWR N/A
- Revenue
- AXTA $5,166,000,000.00
- ARWR $572,976,000.00
- Revenue This Year
- AXTA N/A
- ARWR $21,287.22
- Revenue Next Year
- AXTA $2.24
- ARWR N/A
- P/E Ratio
- AXTA $13.86
- ARWR N/A
- Revenue Growth
- AXTA N/A
- ARWR 2816.20
- 52 Week Low
- AXTA $26.28
- ARWR $9.57
- 52 Week High
- AXTA $41.66
- ARWR $43.69
- Technical
- Relative Strength Index (RSI)
- AXTA 53.87
- ARWR 54.82
- Support Level
- AXTA $27.45
- ARWR $37.56
- Resistance Level
- AXTA $30.72
- ARWR $40.94
- Average True Range (ATR)
- AXTA 0.80
- ARWR 2.11
- MACD
- AXTA 0.04
- ARWR -0.38
- Stochastic Oscillator
- AXTA 46.18
- ARWR 32.32
About AXTA Axalta Coating Systems Ltd.
Axalta Coating Systems Ltd is a manufacturer, marketer and distributor of high-performance coatings systems. It operates in two segments, The Performance Coatings segment provides liquid and powder coatings solutions to a fragmented and local customer base. Its end markets include refinish and industrial. The Mobility Coatings segment relates to the provision of coating technologies to original equipment manufacturers of light and commercial vehicles. The company operates in the geographic areas of North America, EMEA countries, Asia-Pacific, and Latin America.
About ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.